1. bookVolume 51 (2017): Issue 1 (January 2017)
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Open Access

Intense blue light therapy during the night-time does not suppress the rhythmic melatonin biosynthesis in a young boy

Published Online: 17 Feb 2017
Volume & Issue: Volume 51 (2017) - Issue 1 (January 2017)
Page range: 31 - 34
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Abstract

Objective. Melatonin is a hormone predominantly synthesized and secreted during the night by the pineal gland. Artificial light at night, especially its blue part, acutely suppresses the melatonin production. Th e aim of the present study was to find out, whether an intense blue light phototherapy of severe hyperbilirubinemia, may suppress the melatonin production during the night when the eyes will be properly protected by a sleep mask.

Methods. The main melatonin metabolite, 6-sulphatoxymelatonin was measured in urine in a nine-year old boy suffering from the Crigler-Najjar syndrome type I. The boy was treated during the sleep period with an intense blue light (to 1800 lx) 10 h/day, since his birth. During the phototherapy, his eyes were protected with a sleep mask. The concentration of 6-sulphatoxymelatonin was determined in the first morning urine and urine collected afternoon during the six days. The patient was exposed to phototherapy for three nights, two nights without and the last one with the treatment. The control urine samples were obtained from 8 healthy nine-year old boys. The level of 6-sulphatoxymelatonin was measured by radioimmunoassay and the data were normalized to urinary creatinine.

Results. A distinct melatonin production rhythm was found and 6-sulphatoxymelatonin concentration in urine of the patient was comparable with the values obtained by the control group. No differences in 6-sulphatoxymelatonin levels were found between the nights with and without the phototherapy applied.

Conclusions. We conclude that the whole night treatment of hyperbilirubinemia with intense blue light has negligible side effect on the rhythmic melatonin production, when the eyes are sufficiently protected by the sleep mask.

Keywords

Bojkowski CJ, Aldhous ME, English J, Franey C, Poulton AL, Skene DJ, Arendt J. Suppression of nocturnal plasma melatonin and 6-sulphatoxymelatonin by bright and dim light in man. Horm Metab Res 19, 437-440, 1987a.10.1055/s-2007-10118463692439Search in Google Scholar

Bojkowski CJ, Arendt J, Shih MC, Markey SP. Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin. Clin Chem 33, 1343-1348, 1987b.10.1093/clinchem/33.8.1343Search in Google Scholar

Brainard GC, Sliney D, Hanifi n JP, Glickman G, Byrne B, Greeson JM, Jasser S, Gerner E, Rollag MD. Sensitivity of the human circadian system to short-wavelength (420-nm) light. J Biol Rhythms 23, 379-386, 2008.10.1177/074873040832308918838601Search in Google Scholar

Campbell SS, Murphy PJ. Extraocular circadian phototransduction in humans. Science 279, 396-399, 1998.10.1126/science.279.5349.3969430592Search in Google Scholar

Chen A, Du L, Xu Y, Chen L, Wu Y. Th e eff ect of blue light exposure on the expression of circadian genes: bmal1 and cryptochrome 1 in peripheral blood mononuclear cells of jaundiced neonates. Pediatr Res 58, 1180-1184, 2005.10.1203/01.pdr.0000183663.98446.0516306190Search in Google Scholar

Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, Dorko K, Sauter BV, Strom SC. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338, 1422-1426, 1998.10.1056/NEJM1998051433820049580649Search in Google Scholar

Graham C, Cook MR, Kavet R, Sastre A, Smith DK. Prediction of nocturnal plasma melatonin from morning urinary measures. J Pineal Res 24, 230-238, Erratum in: J Pineal Res 26, 128, 1999, 1998.Search in Google Scholar

Hardeland R, Cardinali DP, Srinivasan V, Spence DW, Brown GM, Pandi-Perumal SR. Melatonin - a pleiotropic, orchestrating regulator molecule. Prog Neurobiol 93, 350-384, 2011.10.1016/j.pneurobio.2010.12.00421193011Search in Google Scholar

Karasek M. Melatonin, human aging, and age-related diseases. Exp Gerontol 39, 1723-1729, 2004.10.1016/j.exger.2004.04.01215582288Search in Google Scholar

McIntyre IM, Norman TR, Burrows GD, Armstrong SM. Human melatonin suppression by light is intensity dependent. J Pineal Res 6, 149-156, 1989.10.1111/j.1600-079X.1989.tb00412.x2915324Search in Google Scholar

Stebelova K, Molcan L, Okuliarova M, Hanuliak P, Hartman P, Hraska J, Zeman M. Th e infl uence of indoor lighting with low blue light dose on urine 6-sulphatoxymelatonin concentrations and sleep efficiency of healthy volunteers. Biological Rhythm Research 46, 137-145, 2015.10.1080/09291016.2014.963949Search in Google Scholar

West KE, Jablonski MR, Warfi eld B, Cecil KS, James M, Ayers MA, Maida J, Bowen C, Sliney DH, Rollag MD, Hanifi n JP, Brainard GC. Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans. J Appl Physiol (1985) 110, 619-626, 2011.10.1152/japplphysiol.01413.200921164152Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo